Table 3.
BARC 1 (n = 10) |
No Bleeding (n = 170) |
p | |
---|---|---|---|
Femoral approach, n (%) | 7 (70%) | 39 (22.9%) | 0.001 |
Concomitant DAPT use, n (%) | 7 (70%) | 68 (40%) | 0.061 |
History of previous hemorrhage, n (%) | 0 | 3 (1.8%) | 0.672 |
Type of stent, n (%) | 0.052 | ||
BMS | 1 (10%) | 76 (44.7%) | |
DES | 8 (80%) | 90 (52.9%) | |
DES + BMS | 1 (10%) | 4 (2.4%) |
BARC, Bleeding Academic Research Consortium; DAPT, dual antiplatelet therapy; BMS, bare metal stent; DES, drug-eluting stent.